These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37191675)

  • 21. Embelin-loaded chitosan gold nanoparticles interact synergistically with ciprofloxacin by inhibiting efflux pumps in multidrug-resistant Pseudomonas aeruginosa and Escherichia coli.
    Khare T; Mahalunkar S; Shriram V; Gosavi S; Kumar V
    Environ Res; 2021 Aug; 199():111321. PubMed ID: 33989619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, Characterizations of Superparamagnetic Fe3O4-Ag Hybrid Nanoparticles and Their Application for Highly Effective Bacteria Inactivation.
    Tung le M; Cong NX; Huy le T; Lan NT; Phan VN; Hoa NQ; Vinh le K; Thinh NV; Tai le T; Ngo DT; Mølhave K; Huy TQ; Le AT
    J Nanosci Nanotechnol; 2016 Jun; 16(6):5902-12. PubMed ID: 27427651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing efficacy of existing antibacterials against selected multiple drug resistant bacteria using cinnamic acid-coated magnetic iron oxide and mesoporous silica nanoparticles.
    Akbar N; Kawish M; Jabri T; Khan NA; Shah MR; Siddiqui R
    Pathog Glob Health; 2022 Oct; 116(7):438-454. PubMed ID: 34937524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Near-infrared laser-controlled nitric oxide-releasing gold nanostar/hollow polydopamine Janus nanoparticles for synergistic elimination of methicillin-resistant Staphylococcus aureus and wound healing.
    Liang Z; Liu W; Wang Z; Zheng P; Liu W; Zhao J; Zhong Y; Zhang Y; Lin J; Xue W; Yu S
    Acta Biomater; 2022 Apr; 143():428-444. PubMed ID: 35227899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-infrared light-controllable on-demand antibiotics release using thermo-sensitive hydrogel-based drug reservoir for combating bacterial infection.
    Gao G; Jiang YW; Jia HR; Wu FG
    Biomaterials; 2019 Jan; 188():83-95. PubMed ID: 30339942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
    Zhang J; Sun Y; Wang Y; Lu M; He J; Liu J; Chen Q; Zhang X; Zhou F; Wang G; Sun X
    Eur J Pharmacol; 2014 Oct; 740():277-84. PubMed ID: 25054686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica-based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections.
    Galhano J; Marcelo GA; Duarte MP; Oliveira E
    Bioorg Chem; 2022 Jan; 118():105470. PubMed ID: 34814085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly biocompatible and recyclable biomimetic nanoparticles for antibiotic-resistant bacteria infection.
    Chen B; Li F; Zhu XK; Xie W; Hu X; Zan MH; Li X; Li QY; Guo SS; Zhao XZ; Jiang YA; Cao Z; Liu W
    Biomater Sci; 2021 Feb; 9(3):826-834. PubMed ID: 33215618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria.
    Foletto VS; da Rosa TF; Serafin MB; Bottega A; Franco LN; de Paula BR; Hörner R
    World J Microbiol Biotechnol; 2021 Feb; 37(3):53. PubMed ID: 33604693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of ciprofloxacin-loaded nano-and microcomposite particles for dry powder inhaler formulations: preparation, in vitro characterisation, and antimicrobial efficacy.
    Topal GR; Devrim B; Eryilmaz M; Bozkir A
    J Microencapsul; 2018 Sep; 35(6):533-547. PubMed ID: 30213209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovotransferrin Antibacterial Peptide Coupling Mesoporous Silica Nanoparticle as an Effective Antibiotic Delivery System for Treating Bacterial Infection In Vivo.
    Ma B; Chen Y; Hu G; Zeng Q; Lv X; Oh DH; Fu X; Jin Y
    ACS Biomater Sci Eng; 2022 Jan; 8(1):109-118. PubMed ID: 34936344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review.
    Adeniji OO; Nontongana N; Okoh JC; Okoh AI
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499363
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Zafar N; Uzair B; Menaa F; Khan BA; Niazi MBK; Alaryani FS; Majrashi KA; Sajjad S
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Study of Antibacterial Effects of Titanium Dioxide Nanoparticles Alone and in Combination with Antibiotics on MDR
    Ahmed FY; Farghaly Aly U; Abd El-Baky RM; Waly NGFM
    Int J Nanomedicine; 2020; 15():3393-3404. PubMed ID: 32523339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ciprofloxacin and antibacterial therapy of respiratory tract infections].
    Ivanov DV; Budanov SV
    Antibiot Khimioter; 2006; 51(5):29-37. PubMed ID: 17310788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.